SANARA MEDTECH INC. (SMTI) Return on equity 2017–2025
SANARA MEDTECH INC. (SMTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-632.5%FY2025 · since FY2017: 323.1% → -632.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -632.5% | -608.0 pp |
| FY2024 | -24.5% | -14.9 pp |
| FY2023 | -9.6% | +9.4 pp |
| FY2022 | -19.0% | +6.9 pp |
| FY2021 | -25.9% | +46.4 pp |
| FY2020 | -72.3% | -28.2 pp |
| FY2019 | -44.0% | +58.3 pp |
| FY2018 | -102.3% | -425.5 pp |
| FY2017 | 323.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SMTI financial trends
SMTI RevenueSMTI Net incomeSMTI Net marginSMTI Gross profitSMTI Gross marginSMTI Operating incomeSMTI Operating marginSMTI Operating cash flowSMTI Free cash flowSMTI Capital expendituresSMTI Stock buybacksSMTI Dividends paidSMTI Total assetsSMTI Total liabilitiesSMTI Shareholders’ equitySMTI overview →